Automated External Defibrillators Subject to Voluntary Field Correction
Cardiac Science, makers of several types of automated external defibrillators, AED, issued a call for a field correction of some of its devices. A problem was discovered that might hinder a resuscitation event, which could lead to severe medical issues including death. The affected models include:
- CardioVive 92531, 92532, and 92533 devices
- Powerheart 9300A, 9300C, 9300D, 9300E, 9390A, and 9390E devices
The notice comes after Cardiac Sciences received 64 complaints concerning four resistors linked to this potential medical device failure. Approximately one out of every 75,000 devices manufactured between August 2003 and August of 2009 are predicted. AEDs manufactured after August 2009 do not have this defect. A software correction will be available in May 2010. Until that time, patients using AED should continue using them and follow the recommended maintenance schedule.
An automated external defibrillators, or AED, are a portable devices used to detect and treat life threatening ventricular fibrillation or ventricular tachycardia in patients. An electrical shock is sent to the heart to stop the event. Obviously, a failure occurring in one of these devices would be life threatening.
Cardiac Science recommends that until the May 2010 software update that patients using these devices continue with their regular use and maintenance. To find out more information on the correction and to register for email follow-ups go online to www.cardiacscience.com/AED175.
If you or a loved one has suffered from a failure of this device to diagnose and treat the cardiac problem, please contact the knowledgeable defective medical device litigators at Schlichter, Bogard & Denton, LLP.